Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Yifan Pharmaceutical Revenue

Yifan Pharmaceutical had revenue of 1.25B CNY in the quarter ending September 30, 2026, a decrease of -2.61%. This brings the company's total for the last twelve months to 4.93B, down -5.60% year-over-year. In the year 2025, Yifan Pharmaceutical had annual revenue of 5.13B, down -0.52%. That makes Yifan Pharmaceutical the 9,086th largest company in the world by revenue and 1,428th in China.

• Revenue (ttm): 4.93B
• Revenue Growth: -5.60%
• P/S Ratio: 1.93
• Revenue / Employee: 1.18M
• Employees: 4,182
• Market Cap: 9.53B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Products Division 4.37B 84.9%
• Pharmaceutical Raw Materials and Polymers 775.05M 15.1%

By Geography

Chart

• China 3.98B 77.5%
• Overseas 1.16B 22.5%

Fiscal year ended Dec 31, 2025 See the full Yifan Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.13B	-26.87M	-0.52%
Dec 31, 2024	5.16B	1.09B	26.84%
Dec 31, 2023	4.07B	231.47M	6.03%
Jan 1, 2023	3.84B	-572.39M	-12.98%
Jan 1, 2022	4.41B	-991.34M	-18.36%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error